Floatz logo

Voluven

Stroke Volume Variation

Severance HospitalN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Stroke Volume Variation cohort.

Asset / SponsorPhaseRating
PENTASTARCH, 130/0.4
Severance Hospital
N/AD

Same molecule, other indications

Voluven is also rated in:

hip fractureDormant
B
Indicative ·
60 / 100
View asset →
kidney cancerDormant
B
Indicative ·
58 / 100
View asset →
prostate cancerDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →